New & Noteworthy

Jul 13, 2018
Pharmaceutical Executive
Outlining a real-world example in which building and operationalizing a patient- and customer-centric commercialization strategy drove a successful launch from a “standing start.”
Jul 13, 2018
Pharmaceutical Executive
The role of insurance and risk management in protecting middle-market distributors from the growing opioid multi-district litigation (MDL).
Jul 10, 2018
Traditional scientific search is broken. AI-supported smart searching is the answer, writes Jane Reed.
Jul 10, 2018
Pharmaceutical Executive
Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Jul 07, 2018
Pharmaceutical Executive
Streamlined clinical research, more guidance speed new cures to patients. Jill Wechsler reports.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 30, 2018
Ron Wince explains how Pragmatic AI allows organizations to start with the basics, create immediate business value and ROI and then increase adoption as their comfort, capabilities and confidence increases.
Jun 23, 2018
Realistic, multisensory training devices can contribute to a drug’s reception in the eyes of both patients and healthcare practitioners, writes Paul Sullivan.
Jun 22, 2018
Josh Reisberg outlines the foundation of a broad defense strategy for generic companies embroiled in Hatch-Waxman litigations.
native1_300x100
lorem ipsum